ABSTRACT
PURPOSE: Our aim was to evaluate the postprandial effect of an oral fat load test (OFLT) rich in unsaturated fatty acids on gene expression profile in peripheral blood mononuclear cells (PBMC) from subjects with abdominal obesity as an insulin resistance model and controls. METHODS: A total of 20 controls and 20 abdominal obese patients were studied. Metabolic parameters and oxidative stress markers were measured with standardized protocols. The whole gene expression at fasting state and after the OFLT (0, 4 and 8 h) was analysed using human HT-12-v4 expression beadchips, from Illumina. RESULTS: We found a significant decrease in plasma glucose, insulin and oxidative stress markers in abdominal obese patients and controls. We found beneficial metabolic postprandial gene expression in three genes: FKBP5, DDIT4 and DHRS9. Following an OFLT, the postprandial mRNA expression of FKBP5, and DDIT4 was downregulated while that of DHRS9 was overexpressed, both in nondiabetic normolipidemic subjects and in insulin-resistant subjects with abdominal obesity. CONCLUSIONS: Our results suggest that an OFLT rich in unsaturated fatty acids downregulates the expression of FKBP5, coding for the glucocorticoid receptor pathway, and that of DDIT4, involved in the oxidative stress response. These changes could favourably influence the insulin resistance and oxidative stress status in the postprandial state.
Subject(s)
Fats, Unsaturated/administration & dosage , Gene Expression Profiling/methods , Leukocytes, Mononuclear/metabolism , Obesity, Abdominal/genetics , Obesity, Abdominal/metabolism , Administration, Oral , Adolescent , Adult , Aged , Blood Glucose/metabolism , Fats, Unsaturated/pharmacology , Female , Humans , Insulin/blood , Male , Middle Aged , Oxidative Stress , Postprandial Period , Young AdultABSTRACT
BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) remains the primary target of therapy in most strategies of dyslipidaemia management focused on cardiovascular disease prevention. Different guidelines have identified specific LDL-C cut-off points as targets for therapeutic intervention. Many clinical situations characterised by dyslipidaemia and elevated triglycerides are common in our environment and in overall industrialised countries. Thus, lipid goals based only on LDL-C could misclassify an important percentage of subjects. The objective of the present study was to establish cut-off point values for apoB and non-HDL-C in relation to the identified LDL-C cut-off points for cardiovascular risk in a South European population. METHODS: We performed a cross-sectional study including 1501 subjects (770 women and 731 men) between 18 and 80 years of age. Samples were collected after 12-14 h of fasting. Cholesterol, HDL-C, triglycerides and apoB levels were measured using direct methods. LDL-C was calculated by the Friedewald formula. Non-HDL-C was calculated as total cholesterol minus HDL-C. RESULTS: The Spearman's rank correlations between apoB and LDL-C (r 0.86, p < 0.0001), and between apoB and non-HDL-C (r 0.91, p < 0.0001) were both significant. The proposed cut-off points for apoB, according to LDL-C goals (70, 100, 130 and 160 mg/dl) in our population are 70, 80, 100 and 115 mg/dl respectively. The proposed cut-off values for non-HDL-C are 100, 120, 150 and 190 mg/dl respectively. CONCLUSION: The established LDL-C cut-off values could not be accurate to estimate cardiovascular risk in subjects with mild hypertriglyceridaemia, as frequently occurs in our Mediterranean population. To take into consideration the burden of atherogenic particles and better classify patients at risk we propose cut-off values for apoB or the equivalent for non-HDL-C. Prospective trials including cardiovascular variables are needed to validate our assumption.
Subject(s)
Apolipoproteins B/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Adolescent , Adult , Aged , Aged, 80 and over , Cardiovascular Diseases/blood , Cardiovascular Diseases/ethnology , Cross-Sectional Studies , Female , Humans , Hypertriglyceridemia/blood , Hypertriglyceridemia/ethnology , Male , Middle Aged , Reference Values , Spain/ethnology , Triglycerides/blood , Young AdultABSTRACT
Background. Recent data suggest that the renin-angiotensin system may be involved in triglyceride (TG) metabolism. We explored the effect of the common A1166C and C573T polymorphisms of the angiotensin II type 1 receptor (AT1R) gene on postprandial lipemia. Methods. Eighty-two subjects measured daytime capillary TG, and postprandial lipemia was estimated as incremental area under the TG curve. The C573T and A1166C polymorphisms of the AT1R gene were determined. Results. Postprandial lipemia was significantly higher in homozygous carriers of the 1166-C allele (9.39 ± 8.36 mM*h/L) compared to homozygous carriers of the 1166-A allele (2.02 ± 6.20 mM*h/L) (P < 0.05). Postprandial lipemia was similar for the different C573T polymorphisms. Conclusion. The 1166-C allele of the AT1R gene seems to be associated with increased postprandial lipemia. These data confirm the earlier described relationships between the renin-angiotensin axis and triglyceride metabolism.
ABSTRACT
Un bezoar es una masa o concreción de material ingerido que se acumula en el estómago, desde donde puede pasar al resto del tracto intestinal. Son poco frecuentes, siendo el más común el fitobezoar. Éste se ha relacionado con la cirugía gástrica y con procesos que alteran la motilidad intestinal, como la gastroparesia diabética o la neuropatía alcohólica. En la mayoría de los casos se descubren de forma casual, y más raramente por la presencia de complicaciones asociadas. Presentamos el caso de un paciente con antecedentes de diabetes tipo 2 e ingesta crónica de alcohol, que presentó un cuadro obstructivo intestinal agudo causado por dos bezoares(AU)
A bezoar is a mass or concretion of ingested material which accumulates in the stomach, from it can progress into the rest of gastrointestinal tract. Bezoars are unusual, being the phytobezoar the most common. Phytobezoar shave been associated with gastric surgery and other pathologies that can alter intestinal motility, as diabetes gastroparesis or alcoholic neuropathy. In most cases they are found incidentally or, more rarely, they are discovered by associated complications. We report the case of a patient with type 2 diabetes and chronic alcoholism that presented an acute intestinal obstruction caused by two bezoars(AU)
Subject(s)
Humans , Male , Middle Aged , Bezoars/complications , Intestinal Obstruction/etiology , Diabetes Mellitus, Type 2/complications , Diabetes Complications/diagnosis , Gastroparesis/diagnosis , Alcoholic Neuropathy/complicationsABSTRACT
BACKGROUND AND AIMS: Xanthine oxidase (XO) has been described as one of the major enzymes producing free radicals in blood. Oxidative stress and inflammatory processes have been implicated in the pathogenesis of endothelial dysfunction and the progression of atherosclerosis but until now, there is little data about the influence of vascular prooxidant systems and inflammation in familial combined hyperlipidemia (FCH). Our goal was to evaluate whether XO activity was altered in FCH and if it was related to the inflammatory process represented by NFkB, IL-6 and hsCRP, and assessing the correlation between XO activity and insulin resistance (IR). METHOD AND RESULTS: 40 Non-related subjects with FCH and 30 control subjects were included, all of them non-diabetic, normotensive and non-smokers. We measured lipid profile, glucose, insulin, uric acid, XO activity, malondialdehyde (MDA), IL-6 and hsCRP in plasma and NFkB activity in circulating mononuclear cells. Patients with FCH showed significantly higher levels of uric acid, XO activity, MDA, NFkB activity, IL-6 and hsCRP than controls. XO activity was independently related to NFkB activity with an odds ratio of 4.082; to IL-6 with an odds ratio of 4.191; and to IR with an odds ratio of 3.830. Furthermore, mean NFkB activity, IL-6 levels, and IR were highest in the highest percentile of XO activity. CONCLUSIONS: Subjects with FCH showed increased XO and NFkB activities and low grade inflammatory markers related to atherosclerosis. XO activity was correlated with higher inflammatory activity and IR. These data could explain, in part, the high cardiovascular disease risk present in these patients.
Subject(s)
Hyperlipidemia, Familial Combined/complications , Inflammation/complications , NF-kappa B/metabolism , Xanthine Oxidase/blood , Xanthine Oxidase/metabolism , Adult , Atherosclerosis/pathology , Biomarkers , C-Reactive Protein/metabolism , Endothelium, Vascular/physiopathology , Female , Free Radicals/metabolism , Humans , Hyperlipidemia, Familial Combined/metabolism , Inflammation/metabolism , Insulin Resistance , Interleukin-6/blood , Interleukin-6/metabolism , Lipid Peroxidation , Lipids/blood , Logistic Models , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Middle Aged , Multivariate Analysis , NF-kappa B/blood , Oxidative StressABSTRACT
BACKGROUND: Few data are available on circulating mononuclear cells nuclear factor-kappa B (NF-kB) activity and plasma xanthine oxidase (XO) activity in heterozygous familial hypercholesterolaemia (FH). The goal of the study was to analyse circulating mononuclear cells NF-kB and plasma XO activities in FH patients. MATERIALS AND METHODS: Thirty FH index patients and 30 normoglycaemic normocholesterolaemic controls matched by age, gender, body mass index, abdominal circumference and homeostasis model assessment index were studied. Plasma XO and inflammatory markers were measured by standard methods. NF-kB was assayed in circulating mononuclear cells. RESULTS: Familial hypercholesterolaemia patients showed a significantly higher NF-kB (75.0 +/- 20.7 vs. 42.7 +/- 16.8 relative luminiscence units) and XO (0.44 +/- 0.13 vs. 0.32 +/- 0.09 mU mL(-1)) activities than controls. In addition, interleukin-1, interleukin-6, high sensitivity C reactive protein (hsCRP) and oxidized LDL (LDL-ox) were also significantly higher in FH patients. In the total group (FH and controls), XO was significantly associated with LDL-cholesterol (LDL-C), apolipoprotein B (apoB), NF-kB and hsCPR, and NF-kB activity was significantly associated with XO, hsCPR, LDL-ox, LDL-C and apoB plasma values. Using multiple regression analysis, XO was independently associated with hsCPR and NF-kB, and NF-kB activity in circulating mononuclear cells was independently associated with apoB and LDL-ox plasma values. CONCLUSION: Familial hypercholesterolaemia patients show increased activities of NF-kB and XO, and higher values of low grade inflammatory markers related to atherosclerosis. NF-kB activity was independently associated with apoB plasma values. These data could explain in part the high cardiovascular disease risk present in these patients.
Subject(s)
Hyperlipoproteinemia Type II/blood , Inflammation/blood , NF-kappa B/blood , Xanthine Oxidase/blood , Adult , Biomarkers/blood , Cardiovascular Diseases/blood , Female , Humans , Hyperlipoproteinemia Type II/metabolism , Inflammation/complications , Interleukin-1/blood , Interleukin-6/blood , Lipoproteins/blood , Male , Middle Aged , Monocytes/metabolism , NF-kappa B/metabolism , Regression Analysis , Risk , Xanthine Oxidase/metabolismABSTRACT
No disponible
No disponible
Subject(s)
Humans , Male , Middle Aged , Arthropathy, Neurogenic/diagnosis , Osteomyelitis/diagnosis , Diagnosis, Differential , Foot DiseasesABSTRACT
La diabetes mellitus tipo 2 conlleva un elevado riesgo cardiovascular. Un componente significativo de este riesgo puede atribuirse a ladislipemia diabética, un agrupamiento de anomalías de los lípidos y las lipoproteínas en el plasma íntimamente relacionadas. Sus principales características son hipertrigliceridemia, descenso del colesterol ligado a lipoproteínas de alta densidad (cHDL) y aumento de las lipoproteínas de baja densidad (LDL) pequeñas y densas. Estas alteraciones se conocen también como la tríada aterogénica. Otros componentes son la elevación de la apolipoproteína (apo) B, la prolongación de la lipemia posprandialy el aumento de las partículas remanentes, ricas en triglicéridos. En los últimos años, numerosos estudios prospectivos han demostrado los beneficios de las estatinas para mejorar el perfil lipídico de la dislipemiadiabética y también para reducir el riesgo cardiovascular de estos pacientes. Las estatinas se consideran el tratamiento fundamental y básico de la dislipemia diabética. Los fibratos pueden usarse en algunos grupos reducidos de pacientes y, generalmente, siempre en combinación con las estatinas. Estudios futuros con nuevos fármacos hipolipemiantesy antidiabéticos permitirán un tratamiento más eficaz de la dislipemiadiabética (AU)
Type 2 diabetes carries an elevated cardiovascular risk. A significant component of this risk can be attributed to diabeticdyslipidemia, a cluster of plasma lipid and lipoprotein abnormalities that are metabolically interrelated. The main characteristics of diabetic dyslipidemia are elevated triglycerides, lowered high-densitylipoproteins (HDL) and raised small, denselow-density lipoproteins (LDL). These alterations are also known as the atherogenic lipid triad. Other components of the atherogenic lipid profile are elevatedapo B levels, prolonged postprandial lipemia and accumulation of triglyceride-richremnant particles in the circulation. In the last few years, several prospective trials have proven the effectiveness of statins in improving diabetic dyslipidemia and in reducing cardiovascular risk. These drugs are therefore considered the initial drug ofchoice for diabetic dyslipidemia. Fibrates can be used in a subset of patients, mostlyin combination with statins. Future trials with new lipid-lowering and antidiabetic agents will hopefully allow more targeted treatment of lipid disorders and postprandiallipemia in type 2 diabetics (AU)
Subject(s)
Humans , Male , Female , Hyperlipidemias/complications , Hyperlipidemias/drug therapy , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Cardiovascular Diseases/complications , Cardiovascular Diseases/epidemiology , Diet, Atherogenic , /therapeutic use , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/prevention & control , Risk Factors , /metabolism , /pharmacologyABSTRACT
La amiodarona puede alterar la función tiroidea en un 15-20% de los pacientes que la toman, dando lugar a hipotiroidismo o hipertiroidismo. La sobrecarga de yodo y la toxicidad directa sobre el tiroides inducida por amiodarona pueden provocar hipertiroidismo. Describimos un caso de tirotoxicosis grave por amiodarona que se diagnosticó buscando la causa que descompensó la cardiopatía de base del paciente, condicionando ésta el pronóstico y el manejo terapéutico. El tratamiento precisó un estrecho seguimiento y se basó en dosis elevadas de propiltiouracilo y dexametasona que no controlaron las consecuencias del hipertiroidismo a nivel cardiaco necesitando la tiroidectomia total. Creemos, con la experiencia aportada, que en determinados casos la cirugía es una opción que debería ser planteada con más precocidad
Amiodarone causes changes in thyroid function tests in about 15-20% of patients, inducing either hypothyroidism or thyrotoxicosis. The iodine load and the destructive thyroiditis caused by amiodarone produce thyrotoxicosis. We report a case of amiodarone-induced thyrotoxicosis diagnosed when investigating the reason for worsening of cardiac funtion. Prognosis and treatment of cardiac disorder were determined by thyrotoxicosis. The management needed a closed monitoring of thryroid function. Treatment was based on high doses of propylthiouracil and dexametasone, but they couldn´t control cardiac condition and surgery was warranted. When amiodarone-induced thyrotoxicosis is refractory to medical treatment, we belive surgery should be considered earlier
Subject(s)
Humans , Male , Aged , Hyperthyroidism/chemically induced , Amiodarone/adverse effects , Hyperthyroidism/surgery , Adrenal Cortex Hormones/adverse effects , Thyroidectomy/methodsABSTRACT
Amiodarone causes changes in thyroid function tests in about 15-20% of patients, inducing either hypothyroidism or thyrotoxicosis. The iodine load and the destructive thyroiditis caused by amiodarone produce thyrotoxicosis. We report a case of amiodarone-induced thyrotoxicosis diagnosed when investigating the reason for worsening of cardiac function. Prognosis and treatment of cardiac disorder were determined by thyrotoxicosis. The management needed a closed monitoring of thyroid function. Treatment was based on high doses of propylthiouracil and dexamethasone, but they couldn t control cardiac condition and surgery was warranted. When amiodarone-induced thyrotoxicosis is refractory to medical treatment, we believe surgery should be considered earlier.
Subject(s)
Amiodarone/adverse effects , Thyrotoxicosis/chemically induced , Thyrotoxicosis/therapy , Aged , Humans , MaleABSTRACT
The relationship between cardiovascular autonomic neuropathy (CVAN) and oesophageal dysfunction in diabetes mellitus has not been well established because reports are contradictory. The aim of this study was to assess oesophageal function and its correlation with CVAN in type 1 diabetic patients without oesophageal symptoms. Forty-six type 1 diabetic patients without oesophageal symptoms (DG) and 34 healthy volunteers (CG) were studied. Both groups underwent CVAN tests and oesophageal manometry and pH-metry. Differences between groups regarding results of cardiovascular autonomic tests and oesophageal studies were statistically analysed. Compared with the CG, the DG group showed insufficient lower oesophageal sphincter (LOS) relaxation and a higher percentage of simultaneous waves (P < 0.01). Patients with CVAN (n = 22) showed a higher prevalence of pathological simultaneous contractions (>10%), and the prevalence of simultaneous waves related to the degree of autonomic neuropathy was: 9% of patients without CVAN, 7% of those suspected to have it and 50% of patients with CVAN (P < 0.001). Factors associated with the presence of pathological simultaneous waves (>10%) were the presence of CVAN and duration of diabetes (P < 0.05, logistic regression analysis). Increase in simultaneous waves and impaired relaxation of LOS are more frequent in diabetic patients with CVAN.
Subject(s)
Autonomic Nervous System Diseases/etiology , Diabetes Mellitus, Type 1/complications , Diabetic Neuropathies/etiology , Esophageal Motility Disorders/etiology , Adult , Blood Pressure , Cardiovascular System/pathology , Cardiovascular System/physiopathology , Diabetes Complications , Diabetes Mellitus, Type 1/physiopathology , Female , Heart Rate , Humans , Hydrogen-Ion Concentration , Male , ManometryABSTRACT
INTRODUCTION: A new method based on self-measurement of diurnal capillary triglycerides (TG) facilitates the study of postprandial lipemia (PL). The objectives of our study are: to evaluate the effect of gender and obesity on PL measured by self-determination of diurnal capillary TG with Accutrend GCT in normolipidemic non-diabetic subjects and subjects with familial combined hyperlipidemia (FCH). MATERIAL AND METHODS: We studied 23 FCH subjects (10 males) and 45 normolipidemic non-diabetic subjects (29 males). All subjects self-determine 3 diurnal capillary TG profiles during a week. RESULTS: In normolipidemic non diabetic subjects significantly higher diurnal TG profiles and area under the curve of TG (AUCTGc) (25.25 +/-9.09 vs 19.71 +/- 6.16 mmolh/l) were found in males compared to females. In FCH subjects these differences were not found and the AUCTGc correlated with BMI (r = 0.510, p < 0.05) and waist circumference (r = 0.453, p < 0.05). Obese subjects (BMI >or= 27 kg/m2) showed diurnal TG profiles and AUCTGc significantly higher than the non-obese. DISCUSSION: Normolipidemic non diabetic females showed a lower PL compared to males, probably due to the effect of estrogens in PL metabolism. Obesity negatively influences PL in normolipidemic non diabetic subjects and subjects with FCH.
Subject(s)
Hyperlipidemias , Obesity/epidemiology , Postprandial Period , Triglycerides/blood , Adult , Anthropometry , Body Mass Index , Cholesterol/blood , Female , Humans , Hyperlipidemias/enzymology , Hyperlipidemias/epidemiology , Hyperlipidemias/genetics , Lipoprotein Lipase/metabolism , Male , Sex FactorsABSTRACT
AIMS: There is evidence of an excess of acute cardiovascular (CV) events in marathon runners. High plasma total homocysteine (tHcy) concentrations are a recognised risk factor for CV events. Therefore, we investigated the changes in plasma tHcy concentrations 24h before and after a marathon race. METHODS AND RESULTS: Twenty-two non-professional male athletes, mean age 35.6 (6.6), range 23-49 years, were studied the day before and 24 h after finishing a marathon race. None of the athletes was a carrier of the MTHFR 677TT genotype and no ingestion of supplements of vitamins (B12, B6, folic acid) was allowed. RESULTS: Changes in plasma folate and plasma vitamin B12 concentrations were not detected post-race, but a significant increase in plasma tHcy concentrations was demonstrated. Plasma tHcy increased 19% 24h after the race. Before the race 20% of the subjects had a plasma tHcy concentration > 10 micromol/l (cut-off point for ischaemic heart disease risk), while after the race 50% had plasma tHcy concentrations> 10 micromol/l. CONCLUSION: An increase in plasma tHcy concentrations was observed after a marathon race in non-professional not well-trained male athletes performing strong physical activity. The potential physiological or pathological implications of this finding are unknown.
Subject(s)
Homocysteine/blood , Running/physiology , Adult , Blood Glucose/analysis , Body Composition , Fasting , Fatty Acids, Nonesterified/blood , Folic Acid/blood , Humans , Insulin/blood , Insulin Resistance , Male , Middle Aged , Myocardial Infarction , Risk Factors , Vitamin B 12/blood , Waist-Hip RatioABSTRACT
Presentamos el caso de una mujer con síndrome de McCune-Albrightcomo paradigma de afección tumoral en múltiples glándulas endocrinas. El diagnóstico de la enfermedad se basó en la presencia de la tríada clásica (lesiones hiperpigmentadas cutáneas de color café con leche, pubertad precoz y displasia fibrosa). Durante su seguimiento presentó hipertiroidismo secundario a bocio multinodular tóxico, hiperparatiroidismo, probablemente secundario a hiperplasia paratiroidea, y acromegalia secundaria a adenoma hipofisario productor de hormona de crecimiento. Se comenta la base molecular de la enfermedad y su amplia expresión fenotípica (AU)
We report the case of a woman with McCune-Albright syndrome as a paradigm of multiple endocrine neoplasia. The diagnosis was based on the presence of the classical triad (cutaneous hyperpigmentation with café-au-lait spots, precocious puberty, and fibrous dysplasia of bone). In addition, during follow-up the patient presented primary hyperthyroidism due to multiple toxic goiter, primary hyperparathyroidism probably due multiple hyperplasia of parathyroid glands and acromegaly due to growth hormone-secreting pituitary adenoma. We discuss the molecular bases of the disease and its heterogeneous phenotypic expression (AU)
Subject(s)
Female , Adult , Humans , Fibrous Dysplasia, Polyostotic/diagnosis , Multiple Endocrine Neoplasia/diagnosis , Goiter, Nodular/complications , Hyperthyroidism/etiology , Hyperparathyroidism, Secondary/etiology , Acromegaly/etiology , Hyperprolactinemia/etiologyABSTRACT
OBJECTIVE: To analyse the relation between overweight, obesity and fat distribution with I/D polymorphism of the angiotensin-converting enzyme (ACE) gene and its association with coronary heart disease (CHD). DESIGN: Cross-sectional, case-control study. SUBJECTS: A total of 185 cases (141 males) who had suffered at least one episode of CHD and 182 controls (127 males). MEASUREMENTS: Body mass index, waist circumference, blood pressure, plasma total cholesterol, triglycerides, HDL cholesterol and fasting glucose were measured with standard methods, genotyping the I/D polymorphism of ACE gene. RESULTS: Obesity and abdominal fat deposit are associated with CHD in women, but not independently. We have found an association between obesity and abdominal fat deposit with the ACE gene I/D polymorphism in subjects with CHD. Subjects with CHD and DD or ID genotypes have significantly higher prevalence of obesity and abdominal fat deposit and higher values of weight and waist circumference. In addition, the DD and ID genotypes increased crude OR of obesity. The DD and ID genotypes of the ACE gene I/D polymorphism and BMI are independently associated with CHD. CONCLUSION: There is a relation between the type and grade of obesity with the genotypes of the ACE gene I/D polymorphism in subjects with CHD.
Subject(s)
Body Constitution/genetics , Coronary Disease/genetics , Obesity/genetics , Peptidyl-Dipeptidase A/genetics , Polymorphism, Genetic , Abdomen , Adipose Tissue/pathology , Aged , Case-Control Studies , Coronary Disease/pathology , Cross-Sectional Studies , Female , Genotype , Humans , Logistic Models , Male , Middle Aged , Obesity/pathology , RiskABSTRACT
BACKGROUND: A Mediterranean eating pattern and diet enriched in monounsaturated fatty acids may result in a favourable daylong lipid profile. METHODS: 19 Spanish males (aged 32 +/- 8 years) and 28 females (34 +/- 8 years) were matched to Dutch subjects on the basis of fasting capillary triglycerides (TGc), gender and age. TGc were self-measured at six fixed time points over three days. Daylong TGc profiles were calculated as areas under the curve (TGc-AUC). RESULTS: Anthropometric parameters and fasting plasma lipids were comparable between Spanish participants and Dutch subjects. Insulin sensitivity (expressed as HOMA) was highest in the Dutch females (1.41 +/- 1.09 vs. 2.09 +/- 1.23 in the Spanish females, p < 0.05). Daylong TGc values were not different between Spanish and Dutch participants. Male Spanish subjects showed the largest daylong TGc increase after lunch, while in the Dutch males, the largest TGc increase was seen after dinner. Total daytime dietary energy and total fat intake were comparable when analysed by gender. However, the Spanish participants had a higher intake of monounsaturated and polyunsaturated fatty acids as percentage of energy. CONCLUSION: There are no major differences in daylong triglyceridaemia between Dutch and Spanish subjects, despite different eating habits and a diet enriched in monounsaturated and polyunsaturated fat in the latter.
Subject(s)
Diet, Mediterranean , Eating/physiology , Lipoproteins/blood , Postprandial Period/physiology , Triglycerides/blood , Adult , Diet Records , Diet Surveys , Fasting/blood , Fasting/physiology , Fatty Acids, Monounsaturated/administration & dosage , Fatty Acids, Monounsaturated/metabolism , Female , Humans , Hypertriglyceridemia/blood , Hypertriglyceridemia/ethnology , Hypertriglyceridemia/metabolism , Lipoproteins/metabolism , Male , Netherlands , Spain , Time Factors , Triglycerides/metabolismABSTRACT
La neoplasia endocrina múltiple tipo 1 (NEM 1) es una enfermedad rara, autosómica dominante, debida a mutaciones localizadas en el gen menin, que asocia hiperparatiroidismo primario, tumores gastroenteropancreáticos y adenomas hipofisarios. La mayoría de los tumores de los islotes pancreáticos se asocian a niveles plasmáticos elevados de polipéptido pancreático (PP), siendo excepcional que únicamente produzcan este péptido. La paciente que presentamos tenía antecedentes de un macroprolactinoma intervenido y una hiperplasia adenomatosa de paratiroides con triple paratiroidectomía. De forma totalmente casual se descubrió en la paciente una tumoración pancreática que resultó ser un PPoma. Dado el curso silente inicial de estos tumores y su potencial malignidad, su diagnóstico precoz es importante. La determinación plasmática de PP es de utilidad para el cribado de estos tumores en sujetos de riesgo, como son los familiares de primer grado en la NEM 1 (AU)
